Cargando…

A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen

Patient: Male, 77-year-old Final Diagnosis: Pulmonary tuberculosis Symptoms: Appetite loss Medication: — Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Mycobacterium tuberculosis (M. tuberculosis) is usually treated by oral antim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karaushi, Haruka, Seki, Masafumi, Miyawaki, Yutaka, Watanabe, Noriyuki, Kamoshita, Fumitaka, Mitsutake, Kotaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562597/ https://www.ncbi.nlm.nih.gov/pubmed/36210541 http://dx.doi.org/10.12659/AJCR.937485

Ejemplares similares

Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects
por: Seki, Masafumi, et al.
Publicado: (2020)

COVID-19 and Listeria Meningitis Treated by Ampicillin, Sulfamethoxazole/Trimethoprim and Meropenem
por: Seki, Masafumi, et al.
Publicado: (2023)

Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Intracellular activity of tedizolid phosphate and ACH-702 versus Mycobacterium tuberculosis infected macrophages
por: Molina-Torres, Carmen A, et al.
Publicado: (2014)

Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates—An in vitro Characterization Study
por: Tang, Ying Wei, et al.
Publicado: (2018)

An Intensified Regimen Containing Linezolid Could Improve Treatment Response in Mycobacterium abscessus Lung Disease
por: Li, Hua, et al.
Publicado: (2019)

In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid
por: Zhang, Huiyun, et al.
Publicado: (2022)

1083. Clinical Efficacy of Tedizolid for the Treatment of Mycobacterium abscessus complex Infections in Solid Organ Transplant Recipients
por: Poon, Yi Kee, et al.
Publicado: (2020)

Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features
por: Seki, Masafumi, et al.
Publicado: (2012)

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
por: Yabuno, Kaori, et al.
Publicado: (2013)

Tedizolid Phosphate: a Next-Generation Oxazolidinone
por: Rybak, Jeffrey M., et al.
Publicado: (2015)

Tedizolid: new data and experiences for clinical practice
por: Lletí, Miguel Salavert, et al.
Publicado: (2021)

Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary Mycobacterium avium Complex Disease
por: Fujita, Kohei, et al.
Publicado: (2016)

Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid
por: Flanagan, Shawn, et al.
Publicado: (2014)

Characteristics of Tedizolid Non-susceptible Enterococcal Clinical Isolates
por: Dhand, Abhay, et al.
Publicado: (2017)

Effect of the human endotoxin challenge on tedizolid tissue penetration
por: Jorda, Anselm, et al.
Publicado: (2022)

Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy
por: Seki, Masafumi, et al.
Publicado: (2022)

471. Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate (TZD) in Adolescents with Acute Bacterial Skin and Skin Structure Tissue Infections (ABSSSI)
por: Bradley, John S, et al.
Publicado: (2019)

Stability of crushed tedizolid phosphate tablets for nasogastric tube administration
por: Kennedy, G, et al.
Publicado: (2015)

Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration
por: Kennedy, Gerard, et al.
Publicado: (2015)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers
por: Flanagan, Shawn, et al.
Publicado: (2018)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
por: Binyamin, Dana, et al.
Publicado: (2018)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
por: Shaw, Timothy David, et al.
Publicado: (2021)

Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate
por: Kalam, Mohd Abul, et al.
Publicado: (2022)

Safety and tolerability of tedizolid as oral treatment for bone and joint infections
por: Miller, Loren G., et al.
Publicado: (2023)

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections
por: Urbina, Olatz, et al.
Publicado: (2013)

306. Safety and Tolerability of Tedizolid as Oral Treatment for Bone and Joint Infections
por: Launer, Bryn, et al.
Publicado: (2018)

Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity
por: Paczkowska-Walendowska, Magdalena, et al.
Publicado: (2020)

1289. Assessing the Safety and Efficacy with Prolonged Use of Tedizolid in Orthopedic Patients
por: Garza, Daniel E, et al.
Publicado: (2023)

Five-year analysis of the in vitro activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programme
por: Carvalhaes, Cecilia G, et al.
Publicado: (2022)

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
por: Ferrández, Olivia, et al.
Publicado: (2016)

2421. Tedizolid Is Well-Tolerated Among Patients Receiving Prolonged Treatment Courses
por: Marini, Rachel V, et al.
Publicado: (2018)

1578. Rifampicin Reduces Tedizolid Concentrations When Co-Administered in Healthy Volunteers
por: Lee, Lawrence, et al.
Publicado: (2019)

Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs
por: Benavent, Eva, et al.
Publicado: (2021)

New developments in the management of severe skin and deep skin structure infections – focus on tedizolid
por: Durkin, Michael J, et al.
Publicado: (2015)

Tedizolid vs Linezolid for the Treatment of Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients
por: Poon, Yi Kee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_me4indnodmd33re11dc3tdgoo5